End-of-day quote
Shanghai S.E.
06:00:00 2024-04-25 pm EDT
|
5-day change
|
1st Jan Change
|
17.26
CNY
|
+2.25%
|
|
+9.73%
|
-24.66%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,776
|
3,227
|
3,213
|
14,490
|
5,936
|
6,451
|
Enterprise Value (EV)
1 |
1,757
|
3,099
|
3,364
|
14,766
|
6,422
|
6,992
|
P/E ratio
|
-249
x
|
573
x
|
228
x
|
1,287
x
|
1,054
x
|
-76.4
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
2.28
x
|
2.86
x
|
2.52
x
|
9.1
x
|
3.18
x
|
3.6
x
|
EV / Revenue
|
2.26
x
|
2.75
x
|
2.64
x
|
9.27
x
|
3.44
x
|
3.9
x
|
EV / EBITDA
|
76.4
x
|
68.2
x
|
51.1
x
|
194
x
|
91.3
x
|
-1,454
x
|
EV / FCF
|
-18.9
x
|
22.6
x
|
-12.2
x
|
-133
x
|
-44.4
x
|
-179
x
|
FCF Yield
|
-5.29%
|
4.43%
|
-8.19%
|
-0.75%
|
-2.25%
|
-0.56%
|
Price to Book
|
4.27
x
|
6.52
x
|
6.3
x
|
27.8
x
|
11.3
x
|
14.7
x
|
Nbr of stocks (in thousands)
|
237,472
|
281,574
|
281,574
|
281,574
|
281,574
|
281,574
|
Reference price
2 |
7.480
|
11.46
|
11.41
|
51.46
|
21.08
|
22.91
|
Announcement Date
|
4/19/19
|
4/13/20
|
4/19/21
|
4/1/22
|
4/3/23
|
4/16/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
777.8
|
1,128
|
1,273
|
1,593
|
1,865
|
1,791
|
EBITDA
1 |
22.98
|
45.4
|
65.83
|
76.17
|
70.35
|
-4.808
|
EBIT
1 |
-18.53
|
-4.725
|
3.107
|
11.49
|
-2.895
|
-90.65
|
Operating Margin
|
-2.38%
|
-0.42%
|
0.24%
|
0.72%
|
-0.16%
|
-5.06%
|
Earnings before Tax (EBT)
1 |
-8.475
|
0.3635
|
13.97
|
1.234
|
-4.985
|
-99.33
|
Net income
1 |
-7.469
|
4.437
|
14.32
|
10.6
|
4.788
|
-84.47
|
Net margin
|
-0.96%
|
0.39%
|
1.13%
|
0.67%
|
0.26%
|
-4.72%
|
EPS
2 |
-0.0300
|
0.0200
|
0.0500
|
0.0400
|
0.0200
|
-0.3000
|
Free Cash Flow
1 |
-92.84
|
137.1
|
-275.4
|
-111.1
|
-144.7
|
-38.97
|
FCF margin
|
-11.94%
|
12.16%
|
-21.64%
|
-6.98%
|
-7.76%
|
-2.18%
|
FCF Conversion (EBITDA)
|
-
|
302.02%
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
3,090.25%
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/19/19
|
4/13/20
|
4/19/21
|
4/1/22
|
4/3/23
|
4/16/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
151
|
276
|
486
|
541
|
Net Cash position
1 |
19.8
|
128
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
2.294
x
|
3.629
x
|
6.911
x
|
-112.5
x
|
Free Cash Flow
1 |
-92.8
|
137
|
-275
|
-111
|
-145
|
-39
|
ROE (net income / shareholders' equity)
|
-1.79%
|
-0.83%
|
2.49%
|
0.26%
|
0.2%
|
-16.3%
|
ROA (Net income/ Total Assets)
|
-1.2%
|
-0.22%
|
0.12%
|
0.41%
|
-0.09%
|
-2.8%
|
Assets
1 |
620.4
|
-2,019
|
11,775
|
2,614
|
-5,210
|
3,016
|
Book Value Per Share
2 |
1.750
|
1.760
|
1.810
|
1.850
|
1.870
|
1.550
|
Cash Flow per Share
2 |
0.5900
|
1.120
|
1.270
|
1.060
|
1.180
|
0.8700
|
Capex
1 |
71.2
|
115
|
164
|
108
|
145
|
156
|
Capex / Sales
|
9.15%
|
10.2%
|
12.87%
|
6.79%
|
7.77%
|
8.71%
|
Announcement Date
|
4/19/19
|
4/13/20
|
4/19/21
|
4/1/22
|
4/3/23
|
4/16/24
|
|
1st Jan change
|
Capi.
|
---|
| -24.66% | 671M | | +7.13% | 7.91B | | -3.15% | 4.66B | | -9.18% | 2.84B | | +1.11% | 2.03B | | -26.56% | 1.12B | | -11.09% | 816M | | -22.71% | 759M | | -13.49% | 755M | | -56.85% | 682M |
Scientific & Precision Equipment
|